Baylosis, Elaiza M.

HRN: 25-25-46  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
CEFTRIAXONE 1G (VIAL)
06/07/2024
06/14/2024
IV
2g
Q24
Presumptive PTB
Waiting Final Action 
06/12/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/12/2024
06/18/2024
IV
300mg
Q12h
PTB (clinical); Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: